These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4822190)

  • 41. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
    Kolygin BA; Kharatishvili ZV
    Vopr Onkol; 1983; 29(8):12-5. PubMed ID: 6688487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
    Melato M; Falconieri G; Giammarini Barsanti A; Mottola A
    Haematologica; 1983; 68(5):675-9. PubMed ID: 6416946
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 45. Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
    Med Lett Drugs Ther; 1970 Aug; 12(17):72. PubMed ID: 5514228
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of lymphogranulomatosis].
    Baĭsogolov GD
    Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
    [No Abstract]   [Full Text] [Related]  

  • 47. [Some methods in clinical distinction and treatment of lymphogranulomatosis of the stomach].
    Zdichynec B
    Vnitr Lek; 1974 Sep; 20(9):932-3. PubMed ID: 4410914
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment maintaining complete remission in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
    [No Abstract]   [Full Text] [Related]  

  • 49. [Possibilities and problems in the synchronization therapy of malignant tumours (author's transl)].
    Elö J
    Laryngol Rhinol Otol (Stuttg); 1976 Jul; 55(7):571-4. PubMed ID: 135192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chemotherapy of Hodgkin's disease with drug combinations].
    Jacquillat C; Weil M; Goguel A; Schaison G; Delobel J; Gemon MF; Brunel-Kotschi R; Teillet F; Boiron M; Bernard J
    Presse Med (1893); 1971 Mar; 79(12):513-8. PubMed ID: 5548259
    [No Abstract]   [Full Text] [Related]  

  • 51. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 53. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synchronization of tumor cell proliferation and the timing of cytostatic drugs.
    Klein HO
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):835-8. PubMed ID: 4569608
    [No Abstract]   [Full Text] [Related]  

  • 56. Herpes Zoster-Varicella infections and lymphoma.
    Goffinet DR; Glatstein EJ; Merigan TC
    Ann Intern Med; 1972 Feb; 76(2):235-40. PubMed ID: 4333227
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of recurrences of lymphogranulomatosis].
    Kovryzhkina TA
    Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chemotherapy of Hodgkin disease with modified MOPP].
    Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
    Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
    [No Abstract]   [Full Text] [Related]  

  • 59. The indication for chemotherapy in the lymphomas.
    Rosenberg SA
    Proc Natl Cancer Conf; 1970; 6():83-9. PubMed ID: 5458149
    [No Abstract]   [Full Text] [Related]  

  • 60. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.